CD8A expression positively correlates with CD8+ T cell and M1 macrophage infiltration, and high-density CD8+ T cells in bladder cancer patients are associated with better immune therapy response and improved prognosis (Zheng et al. 2022; Jansen et al. 2019). The gene discussed is CD8A; the disease is urinary bladder cancer.